Abstract 2060P
Background
The aim of the study is to identify the prevalence and predictors of mental adjustment to cancer in patients who were going to resect lung for non-small cell lung cancer in Korea.
Methods
A total of 697 patients were recruited from September 2021 to October 2022 and completed a survey questionnaire of the Korean version of Mini-Mental Adjustment to Cancer (K-Mini-MAC) which higher mean score denote worse mental adjustment, except for positive attitude (PA) domain. Multivariable logistic regression was analyzed to determine potential predictors of poor adjustment to cancer for each domain of K-mini-MAC, which was defined by the mean score of 2.5 or higher, while PA domain was defined by mean score of 2.5 or lower.
Results
The mean age of study population was 63.2 ± 0.4 years old and 50.4% was male. The proportion of poor mental adjustment was 6.0% (Helpless/Hopeless [HH] domain), 29.6% (Anxious Preoccupation [AP] domain), 19.1% (PA domain), and 30.1% (Cognitive Avoidance [CA] domain). The mean score of each domain was 1.60 ± 0.02 (HH), 2.17 ± 0.02 (AP), 2.83 ± 0.02 (PA), and 2.62 ± 0.02 (CA). Younger age (<65 years old, aOR 1.78, 95% CI 1.15-2.76) and having comorbidity (aOR 1.64, 95% CI 1.09-2.45) were associated with poor mental adjustment in AP domain, while current alcohol drinking was associated with better mental adjustment in AP domain (aOR 0.56, 95% CI 0.32-0.96, vs. non-alcohol drinker). Poor mental adjustment in PA domain was predicted based on Lower education level (≤ middle school, aOR 1.97, 95% CI 1.12-3.46; high school, aOR 2.31, 95% CI 1.23-4.36, vs. ≥ university). There was no significant predictor for mental adjustment in HH and CA domain.
Conclusions
Younger, non-alcohol drinker, having comorbidity and lower educational level was associated with a poor adjustment to cancer. Interventions to help with adjustment to cancer should be focused particularly on these group.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
This research was supported by a grant from the National Research Foundation of Korea (NRF) funded by the Korean government (Grant Number: MSIT; 2019R1A2C2009751).
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2076P - Topical diclofenac for prevention of HFS in patients receiving capecitabine monotherapy: An exploratory subgroup analysis of the D-ToRCH phase III trial
Presenter: Akhil Santhosh
Session: Poster session 06
2077P - A randomized, placebo-controlled trial assessing the efficacy and safety of the combination of superoxide dismutase, alpha lipoic acid, vitamin B12, B1, B2, B6, E, Mg, Zn and a fatty acid for 6 months in the management of chemotherapy induced neuropathic pain
Presenter: Triantafylos Didangelos
Session: Poster session 06
2078P - Evaluation of chemotherapy-induced nausea and vomiting beyond the delayed phase: Results of a survey of healthcare providers in Japan
Presenter: Florian Scotté
Session: Poster session 06
2079P - Naloxegol for the treatment of opioid-induced constipation in patients with cancer pain: A pooled analysis of real-world studies (NALOPOOL)
Presenter: Maria del Carmen Beato Zambrano
Session: Poster session 06
2080P - Incidence and risks of intravenous chemotherapy-induced neutropenia (ICIN) in oncology: A multicenter retrospective cohort study on real-life data
Presenter: Olivia Rohr
Session: Poster session 06
2081P - The therapeutic effect of anti-inflammatory tripeptide cream on hand-foot syndrome related to anticancer drugs: A prospective, randomized, placebo-controlled pilot trial
Presenter: Yaewon Yang
Session: Poster session 06
2082P - TASMAN: An international survey on the knowledge, aTtitudes and clinical pAtternsS of use of Medical Cannabis for caNcer care
Presenter: Marco Filetti
Session: Poster session 06
2083P - Association between VTE location and risk of recurrent, bleeding and death in the international prospective TESEO SEOM cancer cohort
Presenter: Rocío Martín Lozano
Session: Poster session 06
2084P - Cardiovascular (CV) mortality among metastatic cancer patients: A retrospective cohort study
Presenter: Irbaz Riaz
Session: Poster session 06
2085P - Buprenorphine use and cancer outcomes
Presenter: Nosayaba Osazuwa-Peters
Session: Poster session 06